Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size

Development

Volumn 133, Issue 4, 2006, Pages 601-610

  Knapp, Jennifer R ^a,b   Davie, Judith K ^a   Myer, Anita ^a   Meadows, Eric ^a,b   Olson, Eric N ^c   Klein, William H ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Conditional knockout mice; Myogenic bHLH transcription factors; Myogenin; Skeletal muscle growth

Indexed keywords

CRE RECOMBINASE; HELIX LOOP HELIX PROTEIN; MYOD1 PROTEIN; MYOGENIC FACTOR; MYOGENIN;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY GROWTH; BODY SIZE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; GROWTH REGULATION; MALE; MATING; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE MASS; MYOBLAST; NONHUMAN; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SATELLITE CELL; SKELETAL MUSCLE; STEM CELL; TISSUE GROWTH; TRANSGENIC MOUSE; VERTEBRATE;

ALLELES; ANIMALS; ANIMALS, NEWBORN; BODY SIZE; EMBRYO LOSS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOD PROTEIN; MYOGENIC REGULATORY FACTORS; MYOGENIN;

ANIMALIA; MUS MUSCULUS; VERTEBRATA;

EID: 33645055656     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.02249     Document Type: Article

References (55)

1. Allen, R. E., Merkel, R. A. and Young, R. B. (1979). Cellular aspects of muscle growth: myogenic cell proliferation. J. Anim. Sci. 49, 115-127.
2. Arango, N. A., Lovell-Badge, R. and Behringer, R. R. (1999). Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 99, 409-419.
3. Argiles, J. M., Lopez-Soriano, J., Almendro, V., Busquets, S. and Lopez-Soriano, F. J. (2005). Cross-talk between skeletal muscle and adipose tissue: a link with obesity? Med. Res. Rev. 25, 49-65.
4. Baker, J., Liu, J. P., Robertson, E. J. and Efstratiadis, A. (1993). Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 73-82.
5. Bergstrom, D. H., Penn, B. H., Strand, A., Perry, R. L., Rudnicki, M. A. and Tapscott, S. J. (2002). Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell 9, 587-600.
6. Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R. and de Crombrugghe, B. (1999). Sox9 is required for cartilage formation. Nat. Genet. 22, 85-89.
7. Blais, A., Tsikitis, M., Acosta-Alvear, D., Sharan, B., Kluger, Y. and Dynlacht, B. D. (2005). An initial blueprint for myogenic differentiation. Genes Dev. 19, 553-569.
8. Buckingham, M. (2001). Skeletal muscle formation in vertebrates. Curr. Opin. Genet. Dev. 11, 440-448.
9. Carbo, N., Lopez-Soriano, J., Costelli, P., Alvarez, B., Busquets, S., Baccino, F. M., Quinn, L. S., Lopez-Soriano, F. J. and Argiles, J. M. (2001). Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim. Biophys. Acta 1526, 17-24.
10. Cardasis, C. A. and Cooper, G. W. (1975). An analysis of nuclear numbers in individual muscle fibers during differentiation and growth: a satellite cells-muscle fiber growth unit. J. Exp. Zool. 191, 347-358.
11. Chakraborty, T., Brennan, T. and Olson, E. N. (1991). Differential transactivation of a muscle-specific enhancer by myogenic helix-loop-helix proteins is separable from DNA binding. J. Biol. Chem. 266, 2878-2882.
12. Charge, S. B. and Rudnicki, M. A. (2004). Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238.
13. Cheng, T. C., Wallace, M. C., Merlie, J. P. and Olson, E. N. (1993). Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science 261, 215-218.
14. Cheng, T. C., Tseng, B. S., Merlie, J. P., Klein, W. H. and Olson, E. N. (1995). Activation of the myogenin promoter during mouse embryogenesis in the absence of positive autoregulation. Proc. Natl. Acad. Sci. USA 92, 561-565.
15. Cornelison, D. D. and Wold, B. R. (1997). Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191, 270-283.
16. Cornelison, D. D., Olwin, B. B., Rudnicki, M. A. and Wold, B. J. (2000). MyoD(-/-) satellite cells in single-fiber culture are differentiation defective and MRF4 deficient. Dev. Biol. 224, 122-137.
17. Ekmark, M., Gronevik, E., Schjerling, P. and Gundersen, K. (2003). Myogenin induces higher oxidative capacity in pre-existing mouse muscle fibers after somatic DNA transfer. J. Physiol. 548, 259-269.
18. Fisher, M. C., Meyer, C., Garber, G. and Dealy, C. N. Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth. Bone 37, 741-750.
19. Grounds, M. D. (2002). Reasons for the degeneration of aging skeletal muscle tissue: a central role for IGF-1 signaling. Biogerontology 3, 19-24.
20. Hasty, P., Bradley, A., Morris, J. H., Edmondson, D. G., Venuti, J. M., Olson, E. N. and Klein, W. H. (1993). Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364, 501-506.
21. Hayashi, S. and McMahon, A. P. (2002). Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 244, 305-318.
22. Hughes, S. M., Chi, M. M., Lowry, O. H. and Gundersen, K. (1999). Myogenin induces a shift of enzyme activity from glycolytic to oxidative metabolism in muscles of transgenic mice. J. Cell Biol. 145, 633-642.
23. Kablar, B., Krastel, K., Tajbakhsh, S. and Rudnicki, M. A. (2003). Myf5 and MyoD activation define independent myogenic compartments during embryonic development. Dev. Biol. 258, 307-318.
24. Kassar-Duchossoy, L., Gayraud-Morel, B., Gomes, D., Rocancourt, D., Buckingham, M., Shinin, V. and Tajbakhsh, S. (2004). Mrf4 determines skeletal muscle identity in Myf5:MyoD double-mutant mice. Nature 431, 466-471.
25. Kassar-Duchossoy, L., Giacone, E., Gayraud-Morel, B., Jory, A., Gomes, D. and Tajbakhsh, S. (2005). Pax3/Pax7 mark a novel population of primitive myogenic cells during development. Genes Dev. 19, 1426-1431.
26. Li, S., Czubryt, M. P., McAnally, J., Bassel-Duby, R., Richardson, J. A., Wiebel, F. F., Nordheim, A. and Olson, E. N. (2005). Requirement for serum response factor for skeletal muscle growth and maturation by tissue-specific gene deletion in mice. Proc. Natl. Acad. Sci. USA 102, 1082-1087.
27. Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J. and Efstratiadis, A. (1993). Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59-72.
28. McMahon, A. P. and Bradley, A. (1990). The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62, 1073-1085.
29. Megeney, L. A., Kablar, B., Garrett, K., Anderson, J. E. and Rudnicki, M. A. (1996). MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10, 1173-1183.
30. Musaro, A., McCullagh, K. J., Nava, F. J., Olson, E. N. and Rosenthal, N. (1999). IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400, 581-585.
31. Myer, A., Wagner, D. S., Vivian, J. L., Olson, E. N. and Klein, W. H. (1997). Wild-type myoblasts rescue the ability of myogenin-null myoblasts to fuse in vivo. Dev. Biol. 185, 127-138.
32. Myer, A., Olson, E. N. and Klein, W. H. (2001). MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells. Dev. Biol. 229, 340-350.
33. Nabeshima, Y., Hanaoka, K., Hayasaka, M., Esumi, E., Li, S., Nonaka, I. and Nabeshima, Y. (1993). Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364, 532-535.
34. Olson, E. N. and Klein, W. H. (1998). Muscle minus MyoD. Dev. Biol. 202, 153-156.
35. Olson, E. N. and Williams, R. S. (2000). Remodeling muscles with calcineurin. BioEssays 22, 510-519.
36. Ovchinnikov, D. A., Deng, J. M., Ogunrinu, G. and Behringer, R. R. (2000). Col2a1-directed expression of Cre recombination in differentiating chondrocytes in transgenic mice. Genesis 26, 145-146.
37. Peng, X. D., Xu, P. Z., Chen, M. L., Hahn-Windgassen, A., Skeen, J., Jacobs, J., Sundararajan, D., Chen, W. S., Crawford, S. E., Coleman, K. G. et al. (2003). Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17, 1352-1365.
38. Penn, B. H., Bergstrom, D. A., Dilworth, F. J., Bengal, E. and Tapscott, S. J. (2004). A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation. Genes Dev. 18, 2348-2353.
39. Pownall, M. E., Gustafsson, M. K. and Emerson, C. P. (2002). Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu. Rev. Cell Dev. Biol. 18, 747-783.
40. Rawls, A., Morris, J. H., Rudnicki, M., Braun, T., Arnold, H. H., Klein, W. H. and Olson, E. N. (1995). Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis. Dev. Biol. 172, 37-50.
41. Rawls, A., Valdez, M. R., Zhang, W., Richardson, J., Klein, W. H. and Olson, E. N. (1998). Overlapping functions of the myogenic bHLH genes MRF4 and MyoD revealed in double mutant mice. Development 125, 2349-2358.
42. Relaix, F., Rocancourt, D., Mansouri, A. and Buckingham, M. (2005). A Pax3/Pax7-dependent population of skeletal muscle progenitor cells. Nature 435, 948-953.
43. Sabourin, L. A., Girgis-Gabardo, A., Seale, P., Asakura, A. and Rudnicki, M. A. (1999). Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. J. Cell Biol. 144, 631-643.
44. Sauer, B. (1998). Inducible gene targeting in mice using the Cre/lox system. Methods 14, 381-392.
45. Seale, P., Sabourin, L. A., Girgis-Gabardo, A., Mansouri, A., Gruss, P. and Rudnicki, M. A. (2000). Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777-786.
46. Seale, P., Asakura, A. and Rudnicki, M. A. (2001). The potential of muscle stem cells. Dev. Cell 1, 333-342.
47. Smith, A. G. and Muscat, G. E. (2005). Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease. Int. J. Biochem. Cell Biol. 37, 2047-2063.
48. Tapscott, S. J. (2005). The circuitry of a master switch: MyoD and the regulation of skeletal muscle gene transcription. Development 132, 2685-2695.
49. Valdez, M. R., Richardson, J. A., Klein, W. H. and Olson, E. N. (2000). Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. Dev. Biol. 219, 287-298.
50. Venuti, J. M., Morris, J. H., Vivian, J. L., Olson, E. N. and Klein, W. H. (1995). Myogenin is required for late but not early aspects of myogenesis during mouse development. J. Cell Biol. 128, 563-576.
51. Vivian, J. L., Gan, L., Olson, E. N. and Klein, W. H. (1999). A hypomorphic myogenin allele reveals distinct myogenin expression levels required for viability, skeletal muscle development, and sternum formation. Dev. Biol. 208, 44-55.
52. Wang, D. Z., Valdez, M. R., McAnally, J., Richardson, J. and Olson, E. N. (2001). The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development 128, 4623-4633.
53. Yun, K. and Wold, B. (1996). Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8, 877-889.
54. Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P., Esquela, A. F., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M. and Lee, S. J. (2002). Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486-1488.
55. Zoico, E. and Roubenoff, R. (2002). The role of cytokines in regulating protein metabolism and muscle function. Nutr. Rev. 60, 39-51.